Abstract
Stereotactic radiosurgery (SRS) is currently the most common treatment for small- to medium-size vestibular schwannoma (VS). Despite favorable outcome, hearing deterioration still remains an underestimated problem, and the role of hearing rehabilitation is an underinvestigated topic. Among available technologies, cochlear implant (CI) should represent a valid alternative in sporadic VS with single-sided deafness and in neurofibromatosis (NF2) with bilateral profound hearing loss. A literature review of the current clinical data was performed searching scientific literature databases. From all of the articles found, 16 papers were selected. Forty-four subjects treated with radiosurgery (18 male, 19 female, and in 7 cases, sex were not specified; 43 NF2 and 1 sporadic VS) were included in the analysis. Epidemiological, clinical, tumor, treatment, and audiological data were collected. Clinical outcome at last follow-up showed an audiological improvement in 25 of the 44 patients. The audiological outcome was unchanged in 16 cases. Audiological deterioration was recorded in 3 cases. Severity of NF2 phenotype, long history of ipsilateral profound deafness before implantation, progressive tumor growth, and high radiation dose (20 and 40 Gy) were found in patients with a worst audiological outcome. Hearing rehabilitation can improve audiological results for VS patients following SRS in selected cases. Hearing rehabilitation with cochlear implant (CI) in SSD leads to partial restoration of binaural hearing with an improvement in speech comprehension in noise and in sound localization, and partial suppression of subjective incapacitating tinnitus. SRS followed by CI may represent in selected cases a potential emerging option in the management of these patients, aimed at improving their quality of life. Possible implications for the follow-up of these patients are still present, although partially resolved.
Similar content being viewed by others
Data availability
Data collected are published and available in the public domain.
References
Evans DG, Moran A, King A, Saeed S, Gurusinghe N, Ramsden R (2005) Incidence of vestibular schwannoma and neurofibromatosis 2 in the North West of England over a 10-year period: higher incidence than previously thought. Otol Neurotol 26(1):93–97
Plotkin SR, Stemmer-Rachamimov AO, Barker FG II, Halpin C, Padera TP, Tyrrell A, Sorensen AG, Jain RK, di Tomaso E (2009) Hearing improvement after bevacizumab in patients with neurofibromatosis type 2. N Engl J Med 361(4):358–367
Bailo M, Boari N, Franzin A, Gagliardi F, Spina A, del Vecchio A, Gemma M, Bolognesi A, Mortini P (2016) Gamma Knife radiosurgery as primary treatment for large vestibular Schwannomas: clinical results at long-term follow-up in a series of 59 patients. World Neurosurg 95:487–501
Carlson ML, Habermann EB, Wagie AE, Driscoll CL, Van Gompel JJ, Jacob JT, Link MJ (2015) The changing landscape of vestibular schwannoma management in the United States--a shift toward conservatism. Otolaryngol Head Neck Surg 153(3):440–446
Nonaka Y, Fukushima T, Watanabe K, Friedman AH, Sampson JH, McElveen JT Jr et al (2013) Contemporary surgical management of vestibular schwannomas: analysis of complications and lessons learned over the past decade. Neurosurgery 72(2 Suppl Operative):ons103–ons115
McClelland S III, Guo H, Okuyemi KS (2011) Morbidity and mortality following acoustic neuroma excision in the United States: analysis of racial disparities during a decade in the radiosurgery era. Neuro-Oncology 13:1252–1259
Yang I, Aranda D, Han SJ, Chennupati S, Sughrue ME, Cheung SW, Pitts LH, Parsa AT (2009) Hearing preservation after stereotactic radiosurgery for vestibular schwannoma: a systematic review. J Clin Neurosci 16:742–747
Maniakas A, Saliba I (2012) Microsurgery versus stereotactic radiation for small vestibular schwannoma: a meta-analysis of patients with more than 5 years’ follow -up. Otol Neurotol 33:1611–1620
Boari N, Bailo M, Gagliardi F, Franzin A, Gemma M, Del Vecchio A, Bolognesi A, Picozzi P, Mortini P (2014) Gamma Knife radiosurgery for vestibular schwannoma: clinical results at long-term follow-up in a series of 379 patients. J Neurosurg 121(Suppl 2):123–142
Pollock BE, Driscoll CL, Foote RL et al (2006) Patient outcomes after vestibular schwannoma management: a prospective comparison of microsurgical resection and stereotactic radiosurgery. Neurosurgery 59:77–85
Wolbers JG, Dallenga AH, Mendez Romero A, van Linge A (2013) What intervention is best practice for vestibular schwannomas? A systematic review of controlled studies. BMJ Open 3:e 001345
Liu W, Ni M, Jia W, Zhou D, Zhang Q, Jiang Y, Jia G (2015) How to address small- and medium-sized acoustic neuromas with hearing: a systematic review and decision analysis. World Neurosurg 84:283–291
Sidiqi B, Sheth N, Lee A, Safdieh J, Schreiber D (2018) Patterns of stereotactic radiotherapy utilization and fractionation for acoustic neuroma in the United States. J Radiosurg SBRT 5(3):201–207
Arthurs BJ1, Fairbanks RK, Demakas JJ, Lamoreaux WT, Giddings NA, Mackay AR, Cooke BS, Elaimy AL, Lee CM (2011) A review of treatment modalities for vestibular schwannoma. Neurosurg Rev 34(3):265–277. https://doi.org/10.1007/s10143-011-0307-8
Neary WJ, Hillier VF, Flute T et al (2010) Use of a closed set questionnaire to measure primary and secondary effects of neurofibromatosis type 2. J Laryngol Otol 124:720Y8
Carillo C, Kiening M, Bergheimer S, Kalamarides M (2018) Psychological follow-up care of neurofibromatosis type 2 patients and their relatives. Neurochirurgie. 64(5):381–385
van Leeuwen JP, Braspenning JC, Meijer H et al (1996) Quality of life after acoustic neuroma surgery. Ann Otol Rhinol Laryngol 105:423–430
Zeitler DM, Dorman MF (2019) Cochlear implantation for single-sided deafness: a new treatment paradigm. J Neurol Surg B Skull Base 80:178–186
Ramsden R, Khwaja S, Green K et al (2005) Vestibular schwannoma in the only hearing ear: cochlear implant or auditory brainstem implant? Otol Neurotol 26:261Y4
Vermeire K, Van de Heyning P (2009) Binaural hearing after cochlear implantation in subjects with unilateral sensorineural deafness and tinnitus. Audiol Neurotol 14:163–171
Wie OB, Pripp AH, Tvete O (2010) Unilateral deafness in adults: effects on communication and social interaction. Ann Otol Rhinol Laryngol 119(11):772–781
Dwyer NY, Firszt JB, Reeder RM (2014) Effects of unilateral input and mode of hearing in the better ear: self-reported performance using the speech, spatial and qualities of hearing scale. Ear Hear 35(1):126–136
Hassepass F, Arndt S, Aschendorff A, Laszig R, Wesarg T (2016) Cochlear implantation for hearing rehabilitation in single sided deafness after translabyrinthine vestibular schwannoma surgery. Eur Arch Otorhinolaryngol 273:2373–2383
Dagna F, Murri A, Albera R (2016) Cuda D Cochlear implantation in delayed sudden hearing loss after conservative vestibular schwannoma surgery. Acta Otorhinolaryngol Ital 36(5):428–430
Amoodi HA, Makki FM, Cavanagh J, Maessen H, Bance M (2012) Cochlear implant rehabilitation for patients with vestibular schwannoma: report of two cases. Cochlear Implants Int 13(2):124–127
Carlson ML, Breen JT, Driscoll CL, Link MJ, Neff BA, Gifford RH, Beatty CW (2012) Cochlear implantation in patients with neurofibromatosis type 2: variables affecting auditory performance. Otol Neurotol 33:853–862
Lustig LR, Yeagle J, Driscoll CLW, Blevins N, Francis H, Niparko JK (2006) Cochlear implantation in patients with neurofibromatosis type 2 and bilateral vestibular schwannoma. Otol Neurotol 27(4):512–518
Mallory GW, Pollock BE, Foote RL, Carlson ML, Driscoll CL, Link MJ (2014) Stereotactic radiosurgery for neurofibromatosis 2-associated vestibular schwannomas: toward dose optimization for tumor control and functional outcomes. Neurosurgery. 74(3):292–300
Trotter MI, Briggs RJ (2010) Cochlear implantation in neurofibromatosis type 2 after radiation therapy. Otol Neurotol 31(2):216–219
Roehm PC, Mallen-St Clair J, Jethanamest D et al (2011) Auditory rehabilitation of patients with neurofibromatosis type 2 by using cochlear implants. J Neurosurg 115:827–834
Tran Ba Huy P, Kania R, Frachet B, Poncet C, Legac MS (2009) Auditory rehabilitation with cochlear implantation in patients with neurofibromatosis type 2. Acta Otolaryngol 129:971–975
Lassaletta L, Aristegui M, Medina M, Aranguez G, Pérez-Mora RM, Falcioni M, Gavilán J, Piazza P, Sanna M (2016) Ipsilateral cochlear implantation in patients with sporadic vestibular schwannoma in the only or best hearing ear and in patients with NF2. Eur Arch Otorhinolaryngol 273:27–35
Harris F, Tysome JR, Donnelly N, Durie-Gair J, Crundwell G, Tam YC, Knight RD, Vanat ZH, Folland N, Axon P (2017) Cochlear implants in the management of hearing loss in neurofibromatosis type 2. Cochlear Implants Int 18(3):171–179
Costello MS, Golub JS, Barrord JV, Pater L, Pensak ML, Samy RN (2016) Cochlear implantation after radiation therapy for acoustic neuroma. J Radiosurg SBRT 4(1):69–74
Carlson ML, Neff BA, Sladen DP, Link MJ, Driscoll CL (2016) Cochlear implantation in patients with intracochlear and intralabyrinthine schwannomas. Otol Neurotol 37(6):647–653
Mukherjee P, Ramsden JD, Donnelly N, Axon P, Saeed S, Fagan P, Irving RM (2013) Cochlear implants to treat deafness caused by vestibular schwannomas. Otol Neurotol 34:1291–1129
Pisa J, Sulkers J, Butler JB, West M, Hochman JB (2017) Stereotactic radiosurgery does not appear to impact cochlear implant performance in patients with neurofibromatosis type II. J Radiosurg SBRT 5(1):63–71
Tan H, Jia H, Li Y, Zhang Z, Zhu W, Cai Y, Wang WH (2018) Impact of cochlear implantation on the management strategy of patients with neurofibromatosis type 2. Eur Arch Otorhinolaryngol 275(11):2667–2674
Peng KA, Lorenz MB, Otto SR, Brackmann DE, Wilkinson EP (2018) Cochlear implantation and auditory brainstem implantation in neurofibromatosis type 2. Laryngoscope. 128(9):2163–2169
Pai I, Dhar V, Kelleher C, Nunn T, Connor S, Jiang D, O’Connor AF (2013) Cochlear implantation in patients with vestibular schwannoma: a single United Kingdom center experience. Laryngoscope. 123(8):2019–2023
Samii M, Matthies C (1997) Management of 1000 vestibular schwannomas (acoustic neuromas): hearing function in 1000 tumor resections. Neurosurgery 40:248–262
Gardner G, Robertson JH (1988) Hearing preservation in unilateral acoustic neuroma surgery. Ann Otol Rhinol Laryngol 97:55–66
(1995) Committee on Hearing and Equilibrium guidelines for the evaluation of hearing preservation in acoustic neuroma (vestibular schwannoma): American Academy of Otolaryngology-Head Neck Surgery Foundation, Inc. Otolaryngol Head Neck Surg 113(3):179–180. https://doi.org/10.1016/S0194-5998(95)70101-X
Johnson S, Kano H, Faramand A, Pease M, Nakamura A, Hassib M et al (2019 Nov) Long term results of primary radiosurgery for vestibular schwannomas. J Neuro-Oncol 145(2):247–255
Massager N, Nissim O, Delbrouck C, Devriendt D, David P, Desmedt F et al (2006) Role of intracanalicular volumetric and dosimetric parameters on hearing preservation after vestibular schwannoma radiosurgery. Int J Radiat Oncol Biol Phys 64:1331–1340
Yang I, Sughrue ME, Han SJ, Aranda D, Pitts LH, Cheung SW, Parsa AT (2010) A comprehensive analysis of hearing preservation after radiosurgery for vestibular schwannoma. J Neurosurg 112:851–859
Regis J, Tamura M, Delsanti C, Roche PH, Pellet W, Thomassin JM (2008) Hearing preservation in patients with unilateral vestibular schwannoma after gamma knife surgery. Prog Neurol Surg 21:142–151
Pan S-Y, Liu S-A, Sun M-H, Tsou H-K, Lee S-D, Chen Y-J, Sheehan J, Sheu M-L, Pan H-C (2017) Outcome of hearing preservation related to tumor morphologic analysis in acoustic neuromas treated by gamma knife radiosurgery. Radiat Oncol 12:134
Horiba A, Hayashi M, Chernov M, Kawamata T, Okada Y (2016) Hearing preservation after low-dose Gamma Knife radiosurgery of vestibular schwannomas. Neurol Med Chir (Tokyo) 56:186–192
Hayden Gephart MG, Hansasuta A, Balise RR, Choi C, Sakamoto GT, Venteicher AS, Soltys SG, Gibbs IC, Harsh GR, Adler JR, Chang SD (2013) Cochlea radiation dose correlates with hearing loss after stereotactic radiosurgery of vestibular schwannoma. World Neurosurg 80(3–4):359–363
Frischer JM, Gruber E, Schöffmann V, Ertl A, Höftberger R, Mallouhi A, Wolfsberger S, Arnoldner C, Eisner W, Knosp E, Kitz K, Gatterbauer B (2018) Long-term outcome after Gamma Knife radiosurgery for acoustic neuroma of all Koos grades: a single-center study. J Neurosurg 2:1–10. https://doi.org/10.3171/2017.8.JNS171281
Kano H, Kondziolka D, Khan A, Flickinger JC, Lunsford LD (2009) Predictors of hearing preservation after stereotactic radiosurgery for acoustic neuroma. J Neurosurg 111:863–873
Yomo S, Carron R, Thomassin JM, Roche PH, Régis J (2012) Longitudinal analysis of hearing before and after radiosurgery for vestibular schwannoma. Clinical article. J Neurosurg 117:877–885
Chopra R, Kondziolka D, Niranjan A, Lunsford LD, Flickinger JC (2007) Long-term follow-up of acoustic schwannoma radiosurgery with marginal tumor doses of 12 to 13 Gy. Int J Radiat Oncol Biol Phys 68:845–851
Régis J, Roche PH, Delsanti C, Thomassin JM, Ouaknine M, Gabert K, Pellet W (2007) Modern management of vestibular schwannomas. Prog Neurol Surg 20:129–141
Kim CH, Chung KW, Kong DS, Nam DH, Park K, Kim JH, Hong SH, Cho YS, Chung WH, Lee JI (2010) Prognostic factors of hearing preservation after gamma knife radiosurgery for vestibular schwannoma. J Clin Neurosci 17:214–218
Persson O, Bartek J Jr, Shalom NB, Wangerid T, Jakola AS, Förander P (2017) Stereotactic radiosurgery vs. fractionated radiotherapy for tumor control in vestibular schwannoma patients: a systematic review. Acta Neurochir 159:1013–1021
Hasegawa T, Kida Y, Kato T, Iizuka H, Yamamoto T (2011) Factors associated with hearing preservation after Gamma Knife surgery for vestibular schwannomas in patients who retain serviceable hearing. J Neurosurg 115:1078–1086
Régis J, Carron R, Park MC, Soumare O, Delsanti C, Thomassin JM, Roche PH (2010) Wait-and-see strategy compared with proactive Gamma Knife surgery in patients with intracanalicular vestibular schwannomas. J Neurosurg 113(Suppl):105–111
Hirsch A, Norén G, Anderson H (1979) Audiologic findings after stereotactic radiosurgery in nine cases of acoustic neurinomas. Acta Otolaryngol 88:155–160
North HJD, Lloyd SKW (2018) Hearing rehabilitation in neurofibromatosis type 2. Adv Otorhinolaryngol. Basel, Karger 81:93–104
Lloyd SK, Glynn FJ, Rutherford SA, King AT, Mawman DJ, O’Driscoll MP et al (2014) Ipsilateral cochlear implantation after cochlear nerve preserving vestibular schwannoma surgery in patients with neurofibromatosis type 2. Otol Neurotol 35:43–51
North HJ, Mawman D, O’Driscoll M, Freeman SR, Rutherford SA, King AT, Hammerbeck-Ward C, Evans DG, Lloyd SK (2016) Outcomes of cochlear implantation in patients with neurofibromatosis type 2. Cochlear Implants Int 17:172–177
Vincenti V, Pasanisi E, Guida M, Di Trapani G, Sanna M (2008) Hearing rehabilitation in neurofibromatosis type 2 patients: cochlear versus auditory brainstem implantation. Audiol Neurootol 13:273–280
Graham J, Lynch C, Weber B, Stollwerck L, Wei J, Brookes G (1999) The magnetless Clarion cochlear implant in a patient with neurofibromatosis 2. J Laryngol Otol 113:458–463
Nölle C, Todt I, Basta D, Unterberg A, Mautner VF, Ernst A (2003) Cochlear implantation after acoustic tumour resection in neurofibromatosis type 2: impact of intra- and postoperative neural response telemetry monitoring. ORL J Otorhinolaryngol Relat Spec 65:230–234
Neff BA, Wiet RM, Lasak JM, Cohen NL, Pillsbury HC, Ramsden RT, Welling DB (2007) Cochlear implantation in the neurofibromatosis type 2 patient: long-term follow-up. Laryngoscope 117:1069–1072
Arístegui M, Denia A (2005) Simultaneous cochlear implantation and translabyrinthine removal of vestibular schwannoma in an only hearing ear: report of 2 cases (neurofibromatosis type 2 and unilateral vestibular schwannoma). Otol Neurotol 26:205–210
Hoffman RA, Kohan D, Cohen NL (1992) Cochlear implants in the management of bilateral acoustic neuromas. Am J Otolaryngol 13:525–528
Celis-Aguilar E, Lassaletta L, Gavilán J (2012) Cochlear implantation in patients with neurofibromatosis type 2 and patients with vestibular schwannoma in the only hearing ear. Int J Otolaryngol 2012:157497
Jia H, El Sayed MME, Smail M, Mosnier I, Wu H, Sterkers O, Kalamarides M, Bernardeschi D (2018) Neurofibromatosis type 2: hearing preservation and rehabilitation. Neurochirurgie. 64(5):348–354
Douglas SA, Yeung P, Daudia A, Gatehouse S, O’Donoghue GM (2007) Spatial hearing disability after acoustic neuroma removal. Laryngoscope 117(9):1648–1651
Kecskeéti N, Szőnyi M, Küstel M, Gáborján A, Tamás L, Répássy G (2019) Cochlear implantation under local anesthesia: a possible alternative for elderly patients. Eur Arch Otorhinolaryngol 276(6):1643–1647
Harford E, Dodds E (1996) The clinical application of CROS: a hearing aid for unilateral deafness. Arch Otolaryngol 83(5):455–464
Hol MK, Kunst SJ, Snik AF, Bosman AJ, Mylanus EA, Cremers CW (2010) Bone-anchored hearing aids in patients with acquired and congenital unilateral inner ear deafness (Baha CROS): clinical evaluation of 56 cases. Ann Otol Rhinol Laryngol 119(7):447–454
Arndt S, Aschendorff A, Laszig R, Beck R, Schild C, Kroeger S, Ihorst G, Wesarg T (2011) Comparison of pseudo binaural hearing to real binaural hearing rehabilitation after cochlear implantation in patients with unilateral deafness and tinnitus. Otol Neurotol 32(1):39–47
Funes CJ, Mace RA, Macklin EA, Plotkin SR, Jordan JT, Vranceanu AM (2019) First report of quality of life in adults with neurofibromatosis 2 who are deafened or have significant hearing loss: results of a live-video randomized control trial. J Neuro-Oncol 143(3):505–513
Zanoletti E, Mazzoni A, d’Avella D (2019) Hearing preservation in small acoustic neuroma: observation or active therapy? Literature review and institutional experience. Acta Neurochir 161(1):79–83
Walton J, Donnelly NP, Tam YC, Joubert I, Durie-Gair J, Jackson C, Mannion RA, Tysome JR, Axon PR, Scoffings DJ (2014) MRI without magnet removal in neurofibromatosis type 2 patients with cochlear and auditory brainstem implants. Otol Neurotol 35(5):821–825
Todt I, Tittel A, Ernst A, Mittmann P, Mutze S (2017) Pain free 3 T MRI scans in cochlear implantees. Otol Neurotol 38(10):e401–e404
Carlson ML, Neff BA, Link MJ, Lane JI, Watson RE, McGee KP, Bernstein MA, Driscoll CL (2015) Magnetic resonance imaging with cochlear implant magnet in place: safety and imaging quality. Otol Neurotol 36(6):965–971
Sharon JD, Northcutt BG, Aygun N, Francis HW (2016) Magnetic resonance imaging a 1.5 Tesla with a cochlear implant magnet in place: image quality and usability. Otol Neurotol 37:1284–1290
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
This research is based on review of published/publicly reported literature. Therefore this research does not require ethics approval.
Informed consent
Not necessary.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Morselli, C., Boari, N., Artico, M. et al. The emerging role of hearing loss rehabilitation in patients with vestibular schwannoma treated with Gamma Knife radiosurgery: literature review. Neurosurg Rev 44, 223–238 (2021). https://doi.org/10.1007/s10143-020-01257-8
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10143-020-01257-8